Brought to you by 
Envista plans separation from parent Danaher following $643mm IPO
23 Dec 2019
Executive Summary
Danaher Corp.'s dental subsidiary Envista Holdings Corp. (implants, orthodontics, and digital imaging technologies) netted $643mm in its initial public offering of 30.7mm shares (including the overallotment) at $22, the middle of its anticipated $21-24 range.
Deal Industry
- Medical Devices
-
Medical Devices
- Consumables, Central Supplies
- Implantable Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
Deal Status
- Final
Deal Type
-
Financing
- IPO
- Spin-Off
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Envista plans separation from parent Danaher following $643mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice